Morgan Stanley Adjusts Palo Alto Networks Price Target Amid Shifting Demand Trends Huawei Advances Chip Design Method Amid US Restrictions Plans New Smartphone Chips This Fall Mercurys Valuation Climbs to 52 Billion as Fintech Resilience Emerges Seagate Initiates Exchange Agreements for 1859 Million Senior Notes DeepSeek Concerns Overblown Why the Selloff in Nvidia Broadcom and Other AI Titans May Be Excessive SP 500 Presses Higher as Tech Healthcare Rally Offset Financials and Utilities Drag RZC Q1 2026 Earnings Strong EPS Surprise Highlights Resilient Underwriting Performance CCAP Q1 2026 Earnings Slight EPS Miss Amidst Stable Portfolio Performance UAA Q1 2026 Earnings EPS Misses Estimates Stock Rises on Potential Optimism Spire Inc SR Q1 2026 Earnings EPS Beats Expectations Amid Steady Utility Demand JPM Q1 2026 Earnings EPS Beats Estimates by Nearly 8 as Strong Trading and Investment Banking Results Drive Performance New Concept Energy Inc GBR Q3 2023 Earnings Small Profit Achieved as Stock Moves Higher Bold Eagle Acquisition Corp BEAG Inches Up Amid Stable SPAC Trading Voya Global Equity Dividend and Premium Opportunity Fund IGD Edges Higher as Price Approaches Key Resistance Seres Therapeutics MCRB Declines 593 as Selling Pressure Intensifies Marathon Petroleum MPC Pulls Back Amid Broader Energy Weakness Kazia Therapeutics KZIA Faces Sharp Decline as Biotech Volatility Resurfaces Analysts Express Mixed Views on Tech Stocks ServiceTitan Applied Digital and Elastic CNC Q1 2026 Earnings Robust EPS Surprise Drives Stock Higher DraftKings DKNG Tumbles Over 4 as Selling Pressure Mounts AU Q1 2026 Earnings Strong EPS Beat Amidst Robust Gold Prices AZZ Inc Q1 2026 Earnings EPS Surpasses Estimates on Strong Operational Execution ECX Q1 2026 Earnings Significant EPS Miss Amid Challenging Operating Environment Sonoco Products Company SON Q1 2026 Earnings EPS Misses Estimates but Stock Gains on Resilient Outlook CLGN Q4 2025 Earnings Widening Losses Yet Shares Edge Higher on Pipeline Progress MLTX Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline Compass Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Supports Biotechs Pipeline Progress